Switch to:
Isis Pharmaceuticals (NAS:ISIS)
Additional Paid-In Capital
$1,343.9 Mil (As of Mar. 2014)

Isis Pharmaceuticals's quarterly additional paid-in capital increased from Sep. 2013 ($1,315.6 Mil) to Dec. 2013 ($1,324.8 Mil) and increased from Dec. 2013 ($1,324.8 Mil) to Mar. 2014 ($1,343.9 Mil).

Isis Pharmaceuticals's annual additional paid-in capital increased from Dec. 2011 ($1,013.6 Mil) to Dec. 2012 ($1,077.2 Mil) and increased from Dec. 2012 ($1,077.2 Mil) to Dec. 2013 ($1,324.8 Mil).


Definition

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Isis Pharmaceuticals Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
AdditionalPaidInCapital 623.7770.3881.0828.0905.7985.61,000.21,013.61,077.21,324.8

Isis Pharmaceuticals Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
AdditionalPaidInCapital 1,013.61,016.51,019.91,073.71,077.21,091.81,292.71,315.61,324.81,343.9
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide